4.7 Article

Progressive regional atrophy in normal adults with a maternal history of Alzheimer disease

Journal

NEUROLOGY
Volume 76, Issue 9, Pages 822-829

Publisher

LIPPINCOTT WILLIAMS & WILKINS
DOI: 10.1212/WNL.0b013e31820e7b74

Keywords

-

Funding

  1. National Institutes of Aging [R03AG026374, R21 AG029615]
  2. National Institute on Neurological Disorders and Stroke [K23NS058252]
  3. Medivation, Inc.
  4. NIH
  5. Parkinson Foundation of the Heartland
  6. Foundation for Physical Therapy
  7. Elan Corporation
  8. Janssen
  9. Wyeth
  10. Pfizer Inc.
  11. Danone
  12. Dana Foundation

Ask authors/readers for more resources

Objective: Beyond age, having a family history is the most significant risk factor for Alzheimer disease (AD). This longitudinal brain imaging study examines whether there are differential patterns of regional gray matter atrophy in cognitively healthy elderly subjects with (FH+) and without (FH-) a family history of late-onset AD. Methods: As part of the KU Brain Aging Project, cognitively intact individuals with a maternal history (FHm, n = 11), paternal history (FHp, n = 10), or no parental history of AD (FH=, n = 32) similar in age, gender, education, and Mini-Mental State Examination (MMSE) score received MRI at baseline and 2-year follow-up. A custom voxel-based morphometry processing stream was used to examine regional differences in atrophy between FH groups, controlling for age, gender, and APOE epsilon 4 (APOE4) status. We also analyzed APOE4-related atrophy. Results: Cognitively normal FH+ individuals had significantly increased whole-brain gray matter atrophy and CSF expansion compared to FH-. When FH+ groups were split, only FHm was associated with longitudinal measures of brain change. Moreover, our voxel-based analysis revealed that FHm subjects had significantly greater atrophy in the precuneus and parahippocampus/hippocampus regions compared to FH- and FHp subjects, independent of APOE4 status, gender, and age. Individuals with an s4 allele had more regional atrophy in the frontal cortex compared to s4 noncarriers. Conclusions: We conclude that FHm individuals without dementia have progressive gray matter volume reductions in select AD-vulnerable brain regions, specifically the precuneus and parahippocampal gyrus. These data complement and extend reports of regional cerebral metabolic differences and increases in amyloid-beta burden in FHm subjects, which may be related to a higher risk for developing AD. Neurology (R) 2011;76:822-829

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available